ciprofloxacin has been researched along with ethidium in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (5.56) | 18.2507 |
2000's | 19 (52.78) | 29.6817 |
2010's | 9 (25.00) | 24.3611 |
2020's | 6 (16.67) | 2.80 |
Authors | Studies |
---|---|
Ahmad, M; Tabassum, F; Tarique, M; Tuteja, R | 1 |
Gaustad, P; Steen, HB; Walberg, M | 1 |
Gutmann, L; Janoir, C; Kitzis, MD; Moreau, NJ; Zeller, V | 1 |
Chaslus-Dancla, E; Cloeckaert, A; Giraud, E; Kerboeuf, D | 1 |
Abramycheva, NIu; Govorun, VM | 1 |
Böddinghaus, B; Böttger, EC; Branzoni, M; Cantoni, R; De Rossi, E; Lopez, G; Riccardi, G; Rodriquez, R; Sander, P; Takiff, H | 1 |
Bébéar, C; Bébéar, CM; Charron, A; Gonzalez, P; Raherison, S; Renaudin, H | 2 |
Gustafson, JE; Kaatz, GW; Price, CT | 1 |
Koshland, DE; McDermott, G; Nikaido, H; Yu, EW; Zgurskaya, HI | 1 |
Blevins, JS; Gustafson, JE; Langevin, MJ; O'Leary, JO; Price, CT; Smeltzer, MS | 1 |
Khan, IA; Kumar, A; Mirza, ZM; Qazi, GN; Verma, V | 1 |
Yang, M | 1 |
Chuong, PH; He, H; Jiao, QC; Liu, XH; Wang, GJ; Wang, LL | 1 |
Bouhours, P; Broussous, S; David, E; Fournier Dit Chabert, J; Joucla, L; Lemaire, M; Marquet, B; Marquez, B; Moreau, N; Neville, L; Pellet-Rostaing, S | 1 |
Brown, DL; Deziel, MR; Drusano, GL; Kulawy, RW; Liu, W; Louie, A | 1 |
Nikaido, H; Su, CC; Yu, EW | 1 |
Ali, F; Ali, I; Gupta, P; Khan, IA; Koul, JL; Koul, S; Kumar, A; Kumar, M; Mirza, ZM; Qazi, GN; Sangwan, PL; Sharma, S; Taneja, SC; Thota, N | 1 |
Garvey, MI; Piddock, LJ | 1 |
Psomas, G | 1 |
Kalia, NP; Khan, IA; Koul, JL; Koul, S; Kumar, A; Qazi, GN; Reddy, MV; Sangwan, PL; Thota, N | 1 |
Abdi-Ali, A; Falsafi, T; Nikname, V; Rahmani-Badi, A | 1 |
Brincat, JP; Carosati, E; Cruciani, G; Fravolini, A; Kaatz, GW; Manfroni, G; Patel, D; Raygada, JL; Sabatini, S | 1 |
Batish, VK; Pagedar, A; Singh, J | 1 |
Christensen, SB; Gúzman, A; Holler, JG; Mølgaard, P; Olsen, CE; Petersen, B; Rasmussen, HB; Slotved, HC | 1 |
Cai, T; Pan, H; Zhang, S; Zhong, HQ | 1 |
Bharate, JB; Bharate, SB; Joshi, P; Khan, IA; Kumar, A; Sharma, S; Singh, S; Vishwakarma, RA; Wani, A | 1 |
Couto, I; Melo-Cristino, J; Rosato, AE; Santos Costa, S; Viveiros, M | 1 |
Bhanuvalli, SR; Ganesh, JS; Lotha, R; Makala, H; Mitra, K; Nagarajan, S; Sivasubramanian, A; Sundaramoorthy, NS; Tiru, V; Ulaganathan, V | 1 |
Araújo, BQ; Arcanjo, DDR; Barreto, HM; Citó, AMGL; de Siqueira Júnior, JP; Ferreira, JHL; Kaatz, GW; Lima Neto, JS; Monção, NBN; Silva, SWC | 1 |
Barreto, HM; da Rocha, CQ; de Alcântara Oliveira, FA; de Oliveira, ABM; de Siqueira-Júnior, JP; de Sousa Andrade, LM; de Sousa Lima Neto, J; Kaatz, GW; Leal, ALAB; Portela, AL | 1 |
Barbosa, CRDS; Bezerra, AH; Coutinho, HDM; da Cunha, FAB; da Silva, L; da Silva, MV; Dashti, S; Kim, B; Macêdo, NS; Silveira, ZS | 1 |
Bandeira, PN; Coutinho, HDM; de Andrade, EM; de Freitas, TS; de Lacerda, BCGV; Dos Santos, HS; Marinho, ES; Marinho, MM; Nogueira, CES; Pereira Junior, FN; Pereira, RLS; Rocha, JE; Rodrigues, LG; Teixeira, AMR; Xavier, JC | 1 |
Abbas, KH; Al-Sallami, D; Alsultan, A; Clarke, SR | 1 |
Araújo, IM; Barbosa-Filho, JM; Bezerra da Cunha, FA; Bezerra, AH; Datiane de Morais Oliveira-Tintino, C; de Sousa Silveira, Z; de Souza-Ferrari, J; Freitas, TS; Macêdo, NS; Marinho, ES; Marinho, MM; Melo Coutinho, HD; Muniz, DF; Nunes da Rocha, M; Ribeiro de Sousa, G; Rocha, JE; Rodrigues Dos Santos Barbosa, C; Silva Dos Santos, H | 1 |
da Silva Lopes, I; de Barros, M; Dos Santos Oliveira Almeida, R; Matiuzzi da Costa, M; Moreira, AJ; Mota, RA; Nero, LA; Scatamburlo Moreira, MA | 1 |
1 review(s) available for ciprofloxacin and ethidium
Article | Year |
---|---|
Discoveries of Tat-TAR interaction inhibitors for HIV-1.
Topics: Amides; Amino Acid Sequence; Animals; Antiviral Agents; Base Sequence; Ciprofloxacin; Drug Design; Drug Evaluation, Preclinical; Ethidium; Gene Products, tat; HIV Long Terminal Repeat; HIV-1; Humans; Imidazoles; Isoquinolines; Molecular Sequence Data; Nucleic Acid Conformation; Protein Binding; Protein Conformation; Pyrroles; RNA, Viral; tat Gene Products, Human Immunodeficiency Virus | 2005 |
35 other study(ies) available for ciprofloxacin and ethidium
Article | Year |
---|---|
Plasmodium falciparum UvrD activities are downregulated by DNA-interacting compounds and its dsRNA inhibits malaria parasite growth.
Topics: Antigens, Protozoan; Cells, Cultured; Daunorubicin; DNA Helicases; DNA, Protozoan; Ethidium; Etoposide; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Netropsin; Nogalamycin; Plasmodium falciparum; RNA, Double-Stranded; RNA, Protozoan | 2014 |
Rapid assessment of ceftazidime, ciprofloxacin, and gentamicin susceptibility in exponentially-growing E. coli cells by means of flow cytometry.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colony Count, Microbial; Escherichia coli; Ethidium; Flow Cytometry; Fluorescent Dyes; Gentamicins; Microbial Sensitivity Tests | 1997 |
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
Topics: 4-Quinolones; Acriflavine; Adenosine Triphosphate; Anti-Infective Agents; Anti-Infective Agents, Local; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cetrimonium; Cetrimonium Compounds; Ciprofloxacin; Drug Resistance, Microbial; Ethidium; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pefloxacin; Phenotype; Quinolones; Streptococcus pneumoniae; Transformation, Bacterial | 1997 |
Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.
Topics: Anti-Infective Agents; Bacterial Proteins; Biological Transport, Active; Cell Membrane Permeability; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli Proteins; Ethidium; Lipoproteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Salmonella enterica | 2000 |
[The participation of the transport-barrier functions of the plasma membrane in the development of fluoroquinolone (ciprofloxacin) resistance in Acholeplasma laidlawii].
Topics: Acholeplasma laidlawii; Anti-Infective Agents; Biological Transport; Cell Membrane; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Ethidium; Microbial Sensitivity Tests | 2000 |
Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance.
Topics: Acriflavine; Anti-Bacterial Agents; Antiporters; Bacterial Proteins; Ciprofloxacin; Doxorubicin; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethidium; Microbial Sensitivity Tests; Mutation; Mycobacterium smegmatis; Rhodamines | 2000 |
Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Enzyme Inhibitors; Ethidium; Fluoroquinolones; Genes, MDR; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma hominis; Pefloxacin; Phenotype; Quinolines; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus.
Topics: Bacterial Proteins; Ciprofloxacin; Drug Interactions; Drug Resistance, Bacterial; Ethidium; Fusidic Acid; Multidrug Resistance-Associated Proteins; Mutation; Proton-Motive Force; Reserpine; Sodium Salicylate; Staphylococcus aureus; Time Factors | 2002 |
Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump.
Topics: Anti-Infective Agents; Anti-Infective Agents, Local; Binding Sites; Carrier Proteins; Cell Membrane; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Crystallization; Crystallography, X-Ray; Dequalinium; Escherichia coli Proteins; Ethidium; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Proteins; Models, Molecular; Multidrug Resistance-Associated Proteins; Protein Binding; Protein Conformation; Protein Structure, Quaternary; Protein Structure, Secondary; Protein Structure, Tertiary; Rhodamines; Static Electricity | 2003 |
Effects of sarA inactivation on the intrinsic multidrug resistance mechanism of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ethidium; Mutation; Staphylococcus aureus; Trans-Activators; Vancomycin | 2004 |
Increased expression of two multidrug transporter-like genes is associated with ethidium bromide and ciprofloxacin resistance in Mycoplasma hominis.
Topics: Amino Acid Sequence; Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Ethidium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mycoplasma hominis; Up-Regulation | 2005 |
Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus.
Topics: Alkaloids; Anti-Infective Agents; Benzodioxoles; Ciprofloxacin; Drug Resistance, Bacterial; Ethidium; Microbial Sensitivity Tests; Piperidines; Polyunsaturated Alkamides; Staphylococcus aureus | 2006 |
[Fluorescence characteristic of terbium-ciprofloxacin complex and its application].
Topics: Animals; Cattle; Ciprofloxacin; DNA; DNA, Neoplasm; Ethidium; Fluorescence; Humans; Hydrogen-Ion Concentration; Spectrometry, Fluorescence; Terbium | 2006 |
Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Proteins; Cell Line, Tumor; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Ethidium; Humans; Indicators and Reagents; Macrolides; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Thiophenes | 2007 |
In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple; Ethidium; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Reserpine; Streptococcus pneumoniae | 2007 |
Ligand-transporter interaction in the AcrB multidrug efflux pump determined by fluorescence polarization assay.
Topics: Ciprofloxacin; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Hydrogen-Ion Concentration; Kinetics; Ligands; Multidrug Resistance-Associated Proteins; Proflavine | 2007 |
Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
Topics: Alkaloids; Anti-Bacterial Agents; Bacterial Proteins; Benzodioxoles; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Ethidium; Microbial Sensitivity Tests; Microbial Viability; Molecular Structure; Multidrug Resistance-Associated Proteins; Mutation; Piperidines; Polyunsaturated Alkamides; Staphylococcus aureus | 2008 |
The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB.
Topics: ATP-Binding Cassette Transporters; Bacterial Proteins; Biological Transport; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ethidium; Gene Order; Mutation; Polymerase Chain Reaction; Protein Isoforms; Reserpine; Streptococcus pneumoniae; Vanadates | 2008 |
Mononuclear metal complexes with ciprofloxacin: Synthesis, characterization and DNA-binding properties.
Topics: Animals; Cattle; Ciprofloxacin; DNA; Ethidium; Iron; Manganese; Metals; Models, Molecular; Molecular Structure; Molybdenum; Organometallic Compounds; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 2008 |
Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
Topics: Alkaloids; Anti-Bacterial Agents; Bacterial Proteins; Benzodioxoles; Ciprofloxacin; Enzyme Inhibitors; Ethidium; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Nucleic Acid Synthesis Inhibitors; Piperidines; Polyunsaturated Alkamides; Staphylococcus aureus | 2008 |
Study of antibiotic resistance by efflux in clinical isolates of Pseudomonas aeruginosa.
Topics: Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethidium; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 2007 |
Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; Ciprofloxacin; Databases, Factual; Drug Resistance, Bacterial; Drug Synergism; Ethidium; Microbial Sensitivity Tests; Models, Molecular; Multidrug Resistance-Associated Proteins; Phenyl Ethers; Propanolamines; Quantitative Structure-Activity Relationship; Staphylococcus aureus; Structure-Activity Relationship; Sulfonamides | 2011 |
Efflux mediated adaptive and cross resistance to ciprofloxacin and benzalkonium chloride in Pseudomonas aeruginosa of dairy origin.
Topics: 2,4-Dinitrophenol; Benzalkonium Compounds; Biofilms; Biological Transport, Active; Ciprofloxacin; Drug Resistance, Bacterial; Ethidium; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Uncoupling Agents | 2011 |
Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees.
Topics: Bacterial Proteins; Biological Assay; Ciprofloxacin; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Ethidium; Inhibitory Concentration 50; Kaempferols; Multidrug Resistance-Associated Proteins; Persea; Plant Extracts; Staphylococcus aureus | 2012 |
Influence of induced ciprofloxacin resistance on efflux pump activity of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport, Active; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Membrane; Ciprofloxacin; Drug Resistance, Bacterial; Ethidium; Humans; Klebsiella pneumoniae; Membrane Transport Proteins; Microbial Sensitivity Tests | 2013 |
Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; Bacterial Proteins; Binding Sites; Biological Transport; Caco-2 Cells; Ciprofloxacin; Coumarins; Dogs; Ethidium; Humans; Madin Darby Canine Kidney Cells; Mice, Inbred BALB C; Models, Molecular; Multidrug Resistance-Associated Proteins; Pyrroles; Rifampin; Staphylococcus aureus | 2015 |
Impact of efflux in the development of multidrug resistance phenotypes in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Biological Transport, Active; Cetrimonium; Cetrimonium Compounds; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ethidium; Gene Expression Profiling; Humans; Membrane Transport Proteins; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2015 |
Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Ciprofloxacin; Colony Count, Microbial; Coumaric Acids; Disease Models, Animal; Drug Synergism; Enzyme Inhibitors; Ethidium; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Multidrug Resistance-Associated Proteins; Muscles; Staphylococcal Infections; Treatment Outcome; Zebrafish | 2018 |
Antimicrobial activity of Mimosa caesalpiniifolia Benth and its interaction with antibiotics against Staphylococcus aureus strains overexpressing efflux pump genes.
Topics: Anti-Bacterial Agents; Antiporters; Bacterial Proteins; Candida albicans; Ciprofloxacin; Drug Resistance, Multiple; Ethidium; Fluoroquinolones; Humans; Methylene Chloride; Microbial Sensitivity Tests; Mimosa; Multidrug Resistance-Associated Proteins; Norfloxacin; Plant Bark; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tetracycline; Tetracycline Resistance | 2019 |
Antimicrobial activity and inhibition of the NorA efflux pump of Staphylococcus aureus by extract and isolated compounds from Arrabidaea brachypoda.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bignoniaceae; Candida albicans; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ethidium; Flavonoids; Fluoroquinolones; Multidrug Resistance-Associated Proteins; Plant Extracts; Staphylococcus aureus | 2020 |
Evaluation of ellagic acid and gallic acid as efflux pump inhibitors in strains of Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drosophila melanogaster; Ellagic Acid; Ethidium; Gallic Acid; Staphylococcus aureus; Tetracycline | 2022 |
ADMET study, spectroscopic characterization and effect of synthetic nitro chalcone in combination with norfloxacin, ciprofloxacin, and ethidium bromide against Staphylococcus aureus efflux pumps.
Topics: Anti-Bacterial Agents; Chalcone; Chalcones; Ciprofloxacin; Ethidium; Humans; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Evaluation of efflux pump inhibitory activity of some plant extracts and using them as adjuvants to potentiate the inhibitory activity of some antibiotics against
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Capsaicin; Ciprofloxacin; Erythromycin; Ethidium; Gentamicins; Humans; Multidrug Resistance-Associated Proteins; Plant Extracts; Propolis; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2023 |
Evaluation of the antibacterial and inhibitory activity of the MepA efflux pump of Staphylococcus aureus by riparins I, II, III, and IV.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Chlorpromazine; Ciprofloxacin; Ethidium; Microbial Sensitivity Tests; Molecular Docking Simulation; Staphylococcus aureus | 2023 |
Multidrug Efflux System-mediated resistance in Staphylococcus aureus under a One Health approach.
Topics: Animals; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Ethidium; Humans; Methicillin-Resistant Staphylococcus aureus; One Health; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2023 |